The management of attentiondeficit hyperactivity disorder in children: Updated 2017: Updated 2017

Keyphrases

• Attention Deficit Hyperactivity Disorder 100%
• Personality Disorders 66%
• Behavioral Intervention 33%
• Abuse Potential 33%
• Diet Therapy 33%
• Family Functioning 33%
• Methylphenidate 33%
• Delinquency 33%
• Fish Oil Supplementation 33%
• Atomoxetine 33%
• Insomnia 33%
• Iron Supplementation 33%
• Substance Abuse 33%
• Drug Intervention 33%
• Polyunsaturated Fatty Acids 33%
• Ferritin Levels 33%
• Good Safety 33%
• Drug Therapy 33%
• Non-stimulants 33%
• New Treatment Options 33%
• Child Growth 33%
• Effects on Growth 33%
• Academic Functioning 33%
• Safety Profile 33%
• Personalized Therapy 33%
• Conduct Disorder 33%
• Antidepressants 33%
• Pharmacist Role 33%
• Stimulants 33%
• Social Functioning 33%
• Neurodevelopmental Disorders 33%
• Alpha-2 Agonists 33%
• Attention-deficit Hyperactivity Disorder Symptoms 33%

Medicine and Dentistry

• Disease 100%
• Hyperactivity 100%
• Attention Deficit Disorder 100%
• Personality Disorder 66%
• Medicine 33%
• Analeptic 33%
• Iron Supplement 33%
• Side Effect 33%
• Conduct Disorder 33%
• Substance Abuse 33%
• Ferritin 33%
• Atomoxetine 33%
• Delinquency 33%
• Prevalence 33%
• Family Functioning 33%
• Drug Therapy 33%
• Methylphenidate 33%
• Personalized Medicine 33%
• Diet Therapy 33%
• Antidepressant 33%
• Polyunsaturated Fatty Acid 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Disease 100%
• Attention Deficit Disorder 100%
• Hyperactivity 100%
• Personality Disorder 66%
• Atomoxetine 33%
• Antidepressant 33%
• Methylphenidate 33%
• Pharmacotherapy 33%
• Conduct Disorder 33%
• Fish Oil 33%
• Prevalence 33%
• Polyunsaturated Fatty Acid 33%
• Side Effect 33%
• Ferritin 33%